Circle Safe
Aubagne
About Circle Safe
Atrial fibrillation is the most common cardiac arrhythmia. The most effective way to prevent recurrence is to perform an interventional procedure: ablation. Most of these procedures are performed by Radiofrequency or by a more recent technique, the Cryoballoon. The latter has many advantages including speed and simplicity but has a complication that is specific to it: the risk of creating Diaphragmatic Paralysis. Circle Safe is developing a solution with the aim of permanently eliminating this complication.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $8.3M
- Last round: Series Unknown (Feb 2025)
- Website: circle-safe.com
Industries & Categories
Manufacturing, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/circle-safe-141938 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.